Affimed Therapeutics Raises €20 Million
Affimed Therapeutics AG, a German antibody developer, has raised €20 million in Series C funding. Return backers included Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk and Orbimed Advisors. The company said that future Series C commitments "at a later date."
30 April 2010•2 mins read
